Why should I order ImpriMed services?

ImpriMed offers a unique precision oncology service that helps you to find the best anticancer drugs for your patients.ImpriMed directly tests a panel of commonly used anticancer drugs on your patients’ live cells in our A2LA accredited lab.In addition, we continually collect patient outcomes that are updated via regular follow-up with pet parents.As our database grows, so does the performance of our anticancer drug response predictions and your ability to develop a personalized treatment plan for each pet patient.So, when you order an ImpriMed service, you are actively contributing to our dataset and helping to improve cancer care for your patients and the ImpiMed user community.

How does ImpriMed ensure the quality and reliability of its immunophenotyping services?

ImpriMed's immunophenotyping services were developed in collaboration with experienced DVMs and are supported by established clinical/laboratory expertise and publications. Our immunophenotyping services are accredited by A2LA and operate under a robust quality management system with ongoing quality control, performance monitoring, and periodic review and update of our assays with our DVM advisors. Our services are routinely benchmarked against established veterinary reference laboratories and show a very high level of concordance.

How long can the media tubes be outside of that temperature before going bad?

We will send you another batch of media tubes you could use. Please make the supply request on the Vet Portal > Request Supplies page.

Is there a way to cancel the order before it is processed if the patient decides they no longer want the ImpriMed test?

In order to cancel the order, please contact us by sending an email to support@imprimedicine.com.

What temperature do the media tubes need to be stored at?

Our proprietary media tubes must be stored in the fridge (36-40° F) before use. Please DO NOT freeze the media tubes.

How much research do you have to support your results?

All of our products are thoroughly validated in-house using clinical outcomes data and we have published multiple peer-reviewed papers demonstrating the efficacy of our predictions (Veterinary Sciences and Veterinary and Comparative Oncology). We have run over 12,000 tests on hematopoietic cells, and over 4,000 canine patients that have benefited from our services. We believe we have more data on canine lymphoma than any other company in the world.